Market revenue in 2022 | USD 630.4 million |
Market revenue in 2030 | USD 1,147.9 million |
Growth rate | 7.8% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.48% in 2022. Horizon Databook has segmented the France molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
Conferences for raising awareness & enhancing skills of researchers are anticipated to positively impact the market growth in the near future. The First Human Genomics international symposium was expected to be hosted by France Génomique in February 2020.
This was aimed at offering access to various platforms and support for research projects. Such ongoing conferences are anticipated to favor the market growth in the coming years.
Furthermore, the French Plan for Genomic Medicine 2025 was initiated in 2015, which was further accelerated by the French National Alliance for Life Sciences and Health in 2016. This is focused on integrating genomic medicine into healthcare by promoting innovation.
Horizon Databook provides a detailed overview of country-level data and insights on the France molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into France molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account